期刊文献+

血清胱蛋白酶抑制剂C在老年2型糖尿病患者早期肾功能损害诊断中的价值

The diagnosis's value of serum cystatin C in the elderly patients with type 2 diabetic early renal damage
下载PDF
导出
摘要 目的探讨血清胱蛋白酶抑制剂C(CysC)在老年2型糖尿病患者早期肾功能损害诊断中的价值。方法将45例平均年龄83岁2型糖尿病住院患者,采用胶乳增强免疫比浊法检测血清胱蛋白酶抑制剂C,同时检测血清肌酐(Scr)、血清尿素氮(Bun)、尿肌酐(Ucr),β2微球蛋白(β2-MG),推算肌酐清除率(Ccr),比较两组患者Bun、Scr、Ccr、CysC、β2-MG,两组各检验方法阳性率结果比较。结果两组患者Bun、Scr、Ccr、CysC、β2-MG之间有统计学差异(P<0.01);在糖尿病组,CysC法阳性率为55.5%,Ccr法阳性率为86.7%,β2-MG法为60%(P<0.001),CysC法与β2-MG法阳性率接近。CysC与Scr、Ccr、β2-MG的相关性分析有统计学意义。结论CysC能够及早发现糖尿病肾病患者肾功能的变化,对其早期的诊断有意义,是一个有价值的指标。 Objective To explore the serum cystatin C (Cys C) in elderly patients with type 2 diabetic diagnosis of elderly renal dysfunction in value. Methods 45 cases of the average age of β2-year-old patients with type 2 diabetic,using latex enthods immunoturtric assay of serum cystatin C,while serum creatinine (Scr),blood ureanitrogen(Bun),urine crea- tinine (Ucr),β2-microglobulin (β2-MG),estininie clearance rat (Ccr),compared two group of patients with Bun,Scr,Ccr, Cys C,β2-MG,were positive rate of the testresuts. Results The two groups of patients with Bun,Scr,Ccr,Cys C,β2-Mg significant difference (P〈0.01),in the diabetic group,the positive reat of Cys C method for 55.5%,Ccr method positive reat of 86.7%,β2-Mg method for 60%(P〈0.001),Cys C method and β2-Mg positive reat close. Cys C and Scr,Ccr,β2-MG analysis of the relevance of statistical significance. Conclusion Cys C to elderly detection of diabtic nephropathy in patients with renal function changes in early diagnosis of its significance,is a valuable indicator.
出处 《中国老年保健医学》 2009年第4期8-9,共2页 Chinese Journal of Geriatric Care
关键词 血清胱蛋白酶抑制剂C 肾小球滤过率 Β2微球蛋白 2型糖尿病患者早期肾功能损害 Serum cystatin C ,Glomerular filtration rate, β2-microglobulin,Type 2 diabetic elderly renal damage
  • 相关文献

参考文献2

二级参考文献19

  • 1Laterza OF, Price CP, Scott MG, Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem, 2002, 48(5): 699-707.
  • 2Aksun SA,Ozmen D,Ozmen B,et al. Beta2-microglohulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy. Exp Clin Endocrinol Diabetes, 2004,112(4): 195-200.
  • 3Mojiminiyi OA, Abdella N. Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus, J Diabetes Complications, 2003, 17(3): 160-168.
  • 4Jovanovic D, Krstivojevic P, Obradovic I, et al. Serum cystatin C and beta2-mieroglobulin as markers of glomerular filtration rate. Ren Fail, 2003, 25(1): 123-133.
  • 5Harmoinen A, Lehtimaki T, Korpela M, et al. Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas. Clin Chem, 2003, 49(7): 1223-1225.
  • 6Christensson A, Ekberg J, Grubb A, et al. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation. Nephron Physiol, 2003, 94(2):p19-p27.
  • 7John GT, Fleming JJ, Talaulikar GS, et al. Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin. Ann Clin Biochem, 2003, 40(Pt 6): 656-658.
  • 8Kos J, Werle B, Lah T, et al. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers, 2000, 15(1): 84-89.
  • 9De-Vos J, Thykjaer T, Tarte K, et al. Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene, 2002, 21(44): 6848-6857.
  • 10Nagai A, Terashima M, Harada T, et al. Cathepsin B and H activities and cystatin C concentrations in cerebrospinal fluid from patients with leptomeningeal metastasis. Clin Chim Acta, 2003, 329(1-2): 53-60.

共引文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部